Armata Pharmaceuticals (ARMP) Current Assets (2016 - 2018)
Armata Pharmaceuticals (ARMP) has disclosed Current Assets for 6 consecutive years, with $5.1 million as the latest value for Q3 2018.
- Quarterly Current Assets fell 35.99% to $5.1 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Sep 2018, down 35.99% year-over-year, with the annual reading at $5.4 million for FY2017, 14.7% down from the prior year.
- Current Assets hit $5.1 million in Q3 2018 for Armata Pharmaceuticals, down from $6.1 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $17.0 million in Q1 2015 to a low of $2.6 million in Q1 2017.
- Historically, Current Assets has averaged $9.1 million across 5 years, with a median of $8.0 million in 2017.
- Biggest five-year swings in Current Assets: plummeted 66.02% in 2014 and later surged 241.52% in 2018.
- Year by year, Current Assets stood at $7.0 million in 2014, then soared by 42.68% to $10.0 million in 2015, then crashed by 36.97% to $6.3 million in 2016, then decreased by 14.7% to $5.4 million in 2017, then decreased by 5.03% to $5.1 million in 2018.
- Business Quant data shows Current Assets for ARMP at $5.1 million in Q3 2018, $6.1 million in Q2 2018, and $8.7 million in Q1 2018.